Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2024-02-14 4:16 pm Sale | 2023-12-31 | 13G | KINNATE BIOPHARMA INC KNTE | Nextech V Oncology S.C.S. SICAV-SIF | 0 0.000% | -2,329,480 (Position Closed) | Filing History |
| 2023-02-14 4:32 pm Sale | 2022-12-31 | 13G | KINNATE BIOPHARMA INC KNTE | Nextech V Oncology S.C.S. SICAV-SIF | 2,329,480 5.300% | -678,763 (-22.56%) | Filing History |
| 2022-02-14 4:00 pm Sale | 2021-12-31 | 13G | PMV PHARMACEUTICALS INC PMVP | Nextech V Oncology S.C.S. SICAV-SIF | 1,385,807 3.100% | -1,142,483 (-45.19%) | Filing History |